GURU.Markets stock price, segment price, and overall market index valuation
The company's share price CUPR
Cuprina, a privately held medical device company, is valued based on its product development progress. Its potential share price will depend on the results of clinical trials, regulatory approvals, and the commercial potential of its developments.
Share prices of companies in the market segment - Treatment
Cuprina Holdings is a medical device company specializing in the development and sale of wound care products and the treatment of chronic ulcers. We've categorized it as a "Treatment" company, and the chart below reflects the overall dynamics of the advanced medical technologies for wound healing sector.
Broad Market Index - GURU.Markets
Cuprina Holdings is a Singapore-based company that provides wound care services using medical maggots for biosurgical debridement. Its unique niche is part of the global market reflected in the GURU.Markets index. The chart below shows the overall dynamics of this sector.
Change in the price of a company, segment, and market as a whole per day
CUPR - Daily change in the company's share price CUPR
For Cuprina Holdings (Cayman) Ltd, a medical technology company, daily volatility reflects sensitivity to scientific data. This metric is an indicator of demand for its wound treatments, particularly in Asian markets.
Daily change in the price of a set of shares in a market segment - Treatment
The healthcare sector, in which Cuprina Holdings (Cayman) Ltd operates, is growing dynamically. This chart reflects the average volatility of the industry. It serves as a benchmark for assessing how sensitive Cuprina's medical product development business is to overall trends and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Cuprina Holdings is a medical technology company. Its success depends on its ability to commercialize its unique developments. Shares of such small, innovative companies often exhibit high volatility, contributing to overall market "noise."
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization CUPR
Cuprina Holdings (Cayman) Ltd's year-over-year performance tells the story of its role in the healthcare market. Its market capitalization over the past 12 months reflects its ability to develop and deliver medical products and services, as well as its adaptability to changing patient needs and regulatory requirements in this complex industry.
Annual dynamics of market capitalization of the market segment - Treatment
Cuprina, as a privately held medical company, likely focuses on niche products. Its growth depends on innovation and its ability to capture market share. Its valuation dynamics will reflect its success in this area, potentially outperforming the sector due to its flexibility and unique offering.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cuprina is a very small and highly speculative company from Singapore. Its stock price since its IPO has had nothing to do with fundamentals or the economy, but has been driven by rumors, hype, and the actions of retail investors, all while bearing enormous country risks.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization CUPR
Cuprina Holdings, as its name suggests, is associated with medicine or healthcare. The monthly performance of such companies depends on demand for their services or products. Regulatory news, quarterly sales data, and contract signings with clinics shape its medium-term trends.
Monthly dynamics of market capitalization of the market segment - Treatment
Cuprina Holdings, operating in the healthcare sector, likely focuses on medical products or services. The dynamics of this sector are generally stable, but depend on the subsegment. If it's biotech, then research is key, while if it's medical equipment, innovation and sales are crucial. The chart below shows the overall investor sentiment against which the company is addressing its objectives.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cuprina Holdings is a healthcare company, likely focused on treatments or medical technologies. Its business depends on scientific developments, clinical successes, and regulatory decisions. The broader market chart allows us to assess the extent to which its specific niche and R&D progress have made its performance independent of overall economic trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization CUPR
Cuprina Holdings is a healthcare company. Its weekly stock price will depend on the specifics of its business, whether it's medical services or products, and will respond to regulatory changes in the healthcare system, as well as overall public demand for healthcare services.
Weekly dynamics of market capitalization of the market segment - Treatment
Cuprina Holdings is a healthcare company. Its weekly stock price will depend on the specifics of its business, whether it's medical services or products, and will respond to regulatory changes in the healthcare system, as well as overall public demand for healthcare services.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cuprina shares (a private company) would live in a world of their own. Their performance would be determined by product news and regulatory approvals. A chart comparing them to the S&P 500 would clearly demonstrate how the stock could move regardless of the broader market.
Market capitalization of the company, segment and market as a whole
CUPR - Market capitalization of the company CUPR
Cuprina Holdings' market capitalization chart, if it were to go public, would tell the story of its hydrogel-based medical product development for wound treatment. Its dynamics would reflect investors' assessment of its technology, clinical trial data, and potential for competition in the large wound care market.
CUPR - Share of the company's market capitalization CUPR within the market segment - Treatment
Cuprina Holdings is a company operating in the healthcare sector, possibly related to medical technology or services. Its share of its segment's market capitalization reflects its scale and market position. The chart below shows how investors assess its business model and growth potential in a competitive industry.
Market capitalization of the market segment - Treatment
Cuprina Holdings is a company operating in the healthcare services sector. The chart below shows the total market capitalization of the healthcare sector. It provides insight into the scale and dynamics of the healthcare industry, a niche the company is seeking to establish itself in.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart represents drug development. Cuprina Holdings is a biopharmaceutical company. Its volatility line will reflect progress in clinical trials and the company's ability to bring new products to market, a challenging task for any biotech startup.
Book value capitalization of the company, segment and market as a whole
CUPR - Book value capitalization of the company CUPR
Cuprina Holdings' book value is its capital, which is dedicated to the development and provision of medical services and products. This is the foundation of its medical expertise and technology. The chart shows how the company is building its material and intellectual base for operations in the healthcare market.
CUPR - Share of the company's book capitalization CUPR within the market segment - Treatment
Cuprina Holdings is a medical company developing biosurgical treatments. Its assets include laboratories and manufacturing facilities. The chart shows the company's share of this niche medical infrastructure.
Market segment balance sheet capitalization - Treatment
Medical technologies, as the BCap_Ges chart shows, are capital-intensive. Cuprina Holdings, operating in this sector, must invest in R&D and production of its products. The chart illustrates the backdrop against which innovation in physical products requires significant investment.
Book value of all companies included in the broad market index - GURU.Markets
Cuprina Holdings' book value is represented by its clinics and capital for providing medical services in Singapore. It reflects the physical scale of the infrastructure that enables the company to provide real medical care to patients in its region.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - CUPR
Cuprina Holdings is a healthcare company. Its market capitalization will be based on the potential of its products or services, not its current assets. Book value is secondary. The MvsBCap chart will reflect progress in its research and commercialization, which is the primary factor in valuing healthcare companies.
Market to book capitalization ratio in a market segment - Treatment
Cuprina Holdings is likely involved in medical technology or pharmaceuticals. The value of such companies is determined by their intellectual property. The chart shows the premium the market pays for their innovations and scientific developments.
Market to book capitalization ratio for the market as a whole
Cuprina Holdings likely operates in the medical or biotech sector. The valuation of such companies is determined by their scientific research, patents, and the potential of their products or technologies. This chart illustrates how investors are investing in science and innovation rather than tangible assets.
Debts of the company, segment and market as a whole
CUPR - Company debts CUPR
Cuprina, a healthcare company, likely uses the capital it raises to conduct research, development, and clinical trials of its products or technologies. For companies in the healthcare sector, the path from idea to market is long and requires significant funding. This chart illustrates how the company manages its resources to achieve its scientific and commercial goals.
Market segment debts - Treatment
Cuprina Holdings is likely involved in the medical sector, possibly developing copper-based products. Developing and commercializing medical or pharmaceutical products requires significant investment. This chart may provide insight into the company's current stage and how it finances its operations.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio CUPR
Cuprina Holdings, a healthcare provider, faces ongoing pressure to invest in technology and staff skills. This chart shows how its debt burden impacts its financial flexibility. In a context of changing regulations and competition, high debt can limit the company's ability to grow and innovate.
Market segment debt to market segment book capitalization - Treatment
Cuprina Holdings, operating in the healthcare sector, requires significant investment to conduct research and bring products to market. This chart shows the overall debt burden in the sector, allowing one to assess how the company's financial strategy for funding its operations compares to industry standards.
Debt to book value of all companies in the market
Cuprina Holdings, judging by its name, may be involved in medicine or biotechnology. For any company in the healthcare sector, overall financial stability, as reflected in this chart, is important. It impacts public and private healthcare spending, as well as the availability of capital for research and the implementation of new treatments.
P/E of the company, segment and market as a whole
P/E - CUPR
This chart of Cuprina Holdings, a healthcare services company, shows how investors evaluate its business and market niche. The dynamics reflect expectations regarding demand for its services, operational efficiency, and ability to adapt to changes in the healthcare system and patient needs.
P/E of the market segment - Treatment
This chart shows the average P/E ratio for the healthcare sector, in which Cuprina Holdings operates. This industry valuation reflects the stable demand for medical services. This metric provides a benchmark for understanding how the market values Cuprina's business model relative to other healthcare providers.
P/E of the market as a whole
Cuprina Holdings is a healthcare company, possibly specializing in medical products or services. Its success depends on the quality of its offerings and the state of the healthcare system. This chart reflects general trends in the sector. It helps understand how the company is finding its niche in the competitive healthcare market and how its valuation is responding to changes in regulation and consumer demand.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company CUPR
Cuprina Holdings is a company operating in the healthcare and medical services sector. Its future revenue depends on demand for its services and the overall situation in the healthcare system. This chart reflects analysts' forecasts for healthcare spending growth and the company's ability to effectively manage and expand its business.
%20P%2FE%20CUPR&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-CUPR&v=1772545681510 "Chart of the company's future (projected) P/E CUPR")
Future (projected) P/E of the market segment - Treatment
Cuprina Holdings is a company operating in the healthcare sector, possibly specializing in medical products or services related to copper or other trace elements. This chart shows how its future revenue expectations compare to the sector average, reflecting an assessment of its scientific foundation and business model.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Treatment&v=1772545681561 "Future (projected) P/E graph of the market segment - Treatment")
Future (projected) P/E of the market as a whole
Cuprina Holdings is a healthcare company operating in a specific niche. Its prospects depend on the development of its specific market, but its valuation as a public company is determined by the overall backdrop set by this chart. During periods of market optimism, even small niche companies in the healthcare sector can attract investor attention.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772545681595 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit CUPR
Cuprina Holdings is a company engaged in the development and implementation of medical technologies. Its profitability depends on the successful commercialization of its products and services in the healthcare market. This graph shows the path from scientific development to stable revenue, reflecting the demand for its solutions among doctors and patients.
Profit of companies in the market segment - Treatment
Cuprina Holdings likely operates in healthcare or biotechnology. For companies in this sector, profitability depends on the effectiveness of their products or services, as well as regulatory approvals. This chart of overall healthcare sector performance shows how innovation and the ability to meet medical needs translate into financial results.
Overall market profit
Cuprina Holdings, operating in the healthcare sector, depends on the adoption of its technologies in medical practice. The overall economic situation, reflected in this chart, influences healthcare system budgets and their willingness to pay for new, more effective treatments and medical products.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company CUPR
Cuprina Holdings is a healthcare company specializing in therapeutic products, possibly in wound care or dermatology. Its success depends on the effectiveness and demand for its products. This chart represents a summary of analyst forecasts for the company's future sales and profitability potential.
%20profit%20of%20the%20company%20CUPR&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-CUPR&v=1772545681668 "Graph of future (projected) profit of the company CUPR")
Future (predicted) profit of companies in the market segment - Treatment
Cuprina Holdings is a healthcare company that likely develops or markets therapeutic products, possibly related to copper, as the name suggests. The success of such companies depends on the proven effectiveness of their therapies. This chart shows profitability projections for the healthcare sector, providing the overall context within which the company is bringing its products to market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Treatment&v=1772545681695 "Graph of future (predicted) profits of companies in a market segment - Treatment")
Future (predicted) profit of the market as a whole
Cuprina Holdings is likely involved in the medical or biotech sectors. Companies in this sector, especially early-stage ones, rely on external financing. The overall corporate profit forecast, reflected in this chart, shapes the investment climate and influences investors' willingness to invest in long-term, risky scientific research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772545681711 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - CUPR
Cuprina Holdings is a healthcare company. This chart shows how the market values its revenue from medical products or services. For a company in the healthcare sector, this ratio reflects the potential of its developments and its share of the target market.
P/S market segment - Treatment
Cuprina Holdings (Cayman) Ltd is a healthcare company specializing in the development and delivery of therapeutic products and services. This chart shows the average revenue estimate in the healthcare sector. It helps understand how investors view the company's business model and its ability to generate revenue in the ever-changing and regulated healthcare industry.
P/S of the market as a whole
Cuprina Holdings is likely a healthcare or biotech company, possibly related to copper as a therapeutic agent. Its value depends on scientific developments. This chart, reflecting the valuation of companies with actual revenue, serves as a benchmark for understanding how investors assess the risks and potential of biotech.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company CUPR
Cuprina Holdings is a healthcare company specializing in the development and sale of medical products. This chart shows how the market estimates its future sales. This estimate depends on demand for its products, the success of its new solutions, and overall trends in the medical industry.
%20P%2FS%20CUPR&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-CUPR&v=1772545681794 "The graph of the company's future (projected) P/S CUPR")
Future (projected) P/S of the market segment - Treatment
Cuprina Holdings is a company focused on developing and commercializing medical technologies and treatments. Its success depends on its ability to bring innovative products to the healthcare market. This chart shows how investors estimate its future sales compared to the medical technology sector.
%20P%2FS%20market%20segment%20graph%20-%20Treatment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Treatment&v=1772545681820 "Future (projected) P/S market segment graph - Treatment")
Future (projected) P/S of the market as a whole
Cuprina Holdings is a healthcare company specializing in treatment. Its success depends on the implementation of its methods and overall healthcare spending. This graph, reflecting the overall economic situation, impacts patient solvency and healthcare facility budgets. Stable economic growth ensures reliable funding for the healthcare system, which is important to the company.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772545681833 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales CUPR
Cuprina Holdings is a healthcare company, possibly specializing in wound care products or other therapeutic solutions. This chart shows revenue from sales of its healthcare products. The dynamics here indicate how successfully the company is bringing its products to market and gaining the trust of the medical community.
Sales of companies in the market segment - Treatment
Cuprina Holdings (Cayman) Ltd. is a healthcare company likely specializing in providing treatment services or developing medical products. The businesses of such companies can be segmented by different therapeutic areas, service types, or product lines. This chart allows you to evaluate the financial performance of one of these areas.
Overall market sales
Cuprina Holdings (Cayman) Ltd. likely operates in healthcare or biotechnology. Companies in this sector strive to solve medical problems, and their success depends on scientific innovation rather than short-term economic cycles. A successful product can create enormous value for society and shareholders, regardless of the state of the overall economy.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company CUPR
Cuprina Holdings is likely a Singapore-based company operating in the healthcare or biotechnology sectors. Its revenue forecast will depend on its specific focus, whether it's drug development, medical device development, or services. It reflects growth expectations for its niche in the Asian market.
%20sales%20of%20the%20company%20CUPR&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-CUPR&v=1772545681920 "Schedule of future (projected) sales of the company CUPR")
Future (projected) sales of companies in the market segment - Treatment
Cuprina Holdings is a healthcare company developing treatment solutions. This chart reflects expectations for the entire healthcare sector. It helps assess analysts' forecasts for trends in the development of new treatments and the demand for innovative medical products, which provides a general backdrop for the entire industry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Treatment&v=1772545681934 "Schedule of future (projected) sales of companies in the market segment - Treatment")
Future (projected) sales of the market as a whole
Cuprina Holdings, a healthcare company. Demand for medical services is generally stable, but the introduction of new treatments and business expansion depend on the overall economic situation. This sales forecast chart reflects the economic conditions that enable the healthcare system to thrive.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772545681937 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality CUPR
Cuprina Holdings (Cayman) Ltd. is likely a biotech or medical device company developing treatments. Being in the research phase, it has no commercial revenue. This chart shows its current financial position, which is dominated by research and clinical trial expenses, which are an investment in future products.
Market segment marginality - Treatment
Cuprina Holdings is a company operating in the medical technology or services sector. In the healthcare sector, profitability depends on the effectiveness of the treatments or diagnostics offered, as well as the ability to receive reimbursement from insurance companies and government systems. The chart shows their operating model.
Market marginality as a whole
Cuprina Holdings (Cayman) Ltd. is likely a medical device or biotechnology company. Profitability in this sector depends on the success of clinical trials, regulatory approval, and product commercialization. This chart shows average profitability, but for CUPR, value is created through scientific innovation and solving unmet medical needs.
Employees in the company, segment and market as a whole
Number of employees in the company CUPR
Cuprina Holdings is a healthcare company. This chart shows its team, which is the driving force behind its growth. In healthcare, whether it's developing drugs or providing services, the qualifications and size of its staff determine a company's ability to achieve its goals.
Share of the company's employees CUPR within the market segment - Treatment
Cuprina Holdings is likely a medical device or biotechnology company. Any activity in healthcare, whether drug development or service provision, requires qualified personnel. This chart provides an overview of its talent pool in this vital sector.
Number of employees in the market segment - Treatment
Cuprina Holdings, judging by its name, may be involved in medical technology or pharmaceuticals. This chart, reflecting employment in the treatment and healthcare sector, shows the overall trend. The company's success depends on its ability to develop and commercialize a product or service that will be in demand in its specific medical niche.
Number of employees in the market as a whole
Cuprina Holdings operates in the medical technology sector. Demand for its products is driven by medical needs and innovation, not by general economic cycles. This chart shows overall employment, but Cuprina is more concerned with proving the effectiveness of its solutions for the healthcare system.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company CUPR (CUPR)
Cuprina Holdings (Cayman) Ltd likely operates in the medical or biotech sector. If the company is in the research stage, this chart will show a high capitalization per employee, reflecting its intellectual capital. If it is a manufacturer, the figure will be lower due to production costs.
%20of%20the%20company%20CUPR%20(CUPR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-CUPR-CUPR&v=1772545682223 "Chart of market capitalization per employee (in thousands of dollars) of the company CUPR (CUPR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Treatment
Cuprina Holdings likely operates in the medical or biotech sector. In the healthcare sector, this metric may reflect either the value of scientific developments or the efficiency of service delivery. Comparison with industry peers will help determine which business model the market values more highly.
%20by%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Treatment&v=1772545682242 "Market capitalization per employee (in thousands of dollars) by market segment - Treatment")
Market capitalization per employee (in thousands of dollars) for the overall market
Cuprina Holdings (Cayman) Ltd. (CUPR) is a healthcare company, possibly focusing on specific treatments or products. The chart shows how the market views its business model and potential in the healthcare industry.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772545682249 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company CUPR (CUPR)
Cuprina Holdings is a medical technology or services company, likely focused on treatments or diagnostics. *Note: Little public information is available.* This chart shows how efficient their business model is. It measures how their team (physicians, engineers, or salespeople) generates revenue by delivering their specialized medical products or services.
%20Chart%20CUPR%20(CUPR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-CUPR-CUPR&v=1772545682265 "Company Profit Per Employee (in thousands of dollars) Chart CUPR (CUPR)")
Profit per employee (in thousands of dollars) in the market segment - Treatment
Cuprina Holdings is a Singaporean biotech company that uses fly larvae for medical purposes, specifically wound cleaning. It's a highly niche and innovative business. This chart demonstrates how productive their unique technology and small team are in creating value, allowing one to appreciate the potential of their unusual approach to medicine.
%20in%20the%20market%20segment%20-%20Treatment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Treatment&v=1772545682278 "Chart of profit per employee (in thousands of dollars) in the market segment - Treatment")
Profit per employee (in thousands of dollars) for the market as a whole
Cuprina Holdings (CUPR) is a Singapore-based healthcare company, likely specializing in wound care. In the MedTech industry, employee profitability is a balance between R&D (new product development) and the sales team's success in promoting these solutions to clinics, generating revenue.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772545682283 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee CUPR (CUPR)
Cuprina Holdings likely operates in the medical or biotech sector. This chart will show how successful its products or services are. Growing revenue per employee will indicate the demand for its solutions in the healthcare market.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-CUPR-CUPR&v=1772545682290 "Sales chart per company employee CUPR (CUPR)")
Sales per employee in the market segment - Treatment
Cuprina Holdings is a medical device company developing wound treatment solutions using biotechnology. This chart compares the company's revenue per employee to the industry average. For an R&D company, this reflects the productivity and relevance of their developments on the path to commercialization.
Sales per employee for the market as a whole
Cuprina Holdings (CUPR) is a Singapore-based biotech company that uses a unique product (a maggot-based biocomposite) to treat chronic wounds (such as diabetic foot). It's a MedTech company. This chart shows the revenue their team generates from sales of this innovative medical product.
Short shares by company, segment and market as a whole
Shares shorted by company CUPR (CUPR)
Cuprina Holdings (CUPR) is a Singapore-based healthcare company, possibly related to wound healing (as per the name "copper"). This chart shows the number of investors skeptical of niche medical technologies from this region.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-CUPR-CUPR&v=1772545682310 "Short Shares Chart for the Company CUPR (CUPR)")
Shares shorted by market segment - Treatment
Cuprina Holdings is a biopharmaceutical company developing treatments for chronic wounds (such as diabetic foot) using medicinal maggots. This chart shows the odds against the wound care sector, reflecting investor skepticism that this unconventional therapy will achieve widespread adoption.
Shares shorted by the overall market
Cuprina Holdings is a medical equipment company (possibly for wound care). This chart reflects general market pessimism. When investors fear a recession, they expect hospitals and clinics to cut back on non-essential supplies and equipment, which will hurt sales.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator CUPR (CUPR)
Cuprina Holdings is a Singapore-based company operating in the healthcare sector or products, possibly related to copper (cuprum). This indicator tracks speculative interest in their developments. It helps determine when the stock is "overheated" (above 70) in anticipation of news or "oversold" (below 30) due to a lack of progress.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-CUPR-CUPR&v=1772545682319 "RSI 14 indicator chart for the company's stock CUPR (CUPR)")
RSI 14 Market Segment - Treatment
Cuprina Holdings is a Singapore-based company operating in the healthcare and care sector. It likely operates hospitals or provides healthcare services. This chart shows overall investor sentiment in the healthcare provider sector. It helps assess whether the CUPR trend is unique or part of a broader trend in healthcare.
RSI 14 for the overall market
Cuprina (CUPR), a healthcare provider, sees this chart as a "flight to safety." Demand for its services isn't driven by euphoria or panic—it's driven by patient health. During times of market panic, investors seek safe havens in stable sectors like healthcare, which supports CUPR.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CUPR (CUPR)
Cuprina Holdings (CUPR) is a Singapore-based healthcare company specializing in the development and production of bioactive dressings for the treatment of complex and chronic wounds. This chart shows the speculative average price target from analysts, based on their belief in the commercialization of this technology and growth in the Asian market.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CUPR-CUPR&v=1772545682349 "A chart showing analyst consensus forecasts for the expected stock price. CUPR (CUPR)")
The difference between the consensus estimate and the actual stock price CUPR (CUPR)
Cuprina Holdings is a Singapore-based biotech company that has developed a unique cell-based bio-patch for treating chronic wounds, such as diabetic foot. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their faith in this regenerative medicine technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CUPR-CUPR&v=1772545682373 "A chart showing the difference between the consensus forecast and the actual stock price. CUPR (CUPR)")
Analyst consensus forecast for stock prices by market segment - Treatment
Cuprina (CUPR) is a Singapore-based biotech company developing innovative treatments for chronic wounds (such as diabetic foot) using medical maggots. This chart shows analysts' overall expectations for the treatment sector, reflecting whether experts believe this "biosurgical" technology will be adopted by the market.
Analysts' consensus forecast for the overall market share price
Cuprina Holdings (CUPR) is likely a Singapore-based microcap company operating in the healthcare or medical services sector. This chart shows the overall risk appetite, reflecting investors' general willingness to invest in opaque and volatile microcaps in emerging markets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index CUPR
Cuprina Holdings is likely a Singaporean MedTech company specializing in wound care. Judging by their name (Cuprum = copper), they may be using copper-based technology (which has antimicrobial properties) to create dressings or therapeutic agents. This chart is a summary of their R&D, reflecting their progress in clinical trials and their path to commercialization.
AKIMA Market Segment Index - Treatment
Cuprina Holdings (CUPR) is a Singapore-based medical technology company known for its MEDIHONEY treatment, which uses medical honey to treat wounds and burns. The chart shows the average index for the segment, helping investors assess how this niche yet effective treatment compares to the sector average.
The AKIM Index for the overall market
Cuprina Holdings is a Singapore-based company specializing in chronic wound care and ostomy care. This chart, showing the average (global/US) market share, serves as a benchmark. It helps assess how this niche medical business compares to overall macroeconomic trends.
